Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
71.95
-1.87 (-2.53%)
Mar 25, 2025, 4:00 PM EST - Market closed
Vaxcyte Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 147.5, with a low estimate of 129 and a high estimate of 163. The average target predicts an increase of 105.00% from the current stock price of 71.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 5 | 6 | 6 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +122.38% | Mar 12, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +122.38% | Feb 26, 2025 |
Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +94.58% | Feb 26, 2025 |
Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | -80.54% | Feb 11, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +87.63% | Dec 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.81
from -3.80
EPS Next Year
-5.34
from -4.81
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 346.5M | ||
Avg | n/a | n/a | 53.2M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.89 | -2.79 | -3.59 | ||
Avg | -4.81 | -5.34 | -6.12 | ||
Low | -6.88 | -8.70 | -7.97 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.